Topical therapy for acne

American Family Physician

Volumn 61, Issue 2, 2000, Pages 357-366

  Russell, John J ^a  

^a ABINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; AZELAIC ACID; BENZAC AC WASH; BENZAMYCIN; BENZOYL PEROXIDE; CLEARASIL; CLINDAMYCIN; ERYTHROMYCIN; RETINOIC ACID; SULFACETAMIDE; SULFUR; TAZAROTENE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ACNE; ANTIBACTERIAL ACTIVITY; COMEDO; CONTACT DERMATITIS; DRY SKIN; HUMAN; HYPOPIGMENTATION; PHOTOSENSITIVITY DISORDER; PROPIONIBACTERIUM ACNES; PSEUDOMEMBRANOUS COLITIS; REVIEW; SEBACEOUS GLAND; SKIN IRRITATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; HUMANS; KERATOLYTIC AGENTS; PATIENT EDUCATION; RETINOIDS; SALICYLIC ACID; SULFACETAMIDE; VEHICLES;

EID: 0034650247     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol 1998;39(2 pt 3):S34-7.
2. Krowchuk DP, Stancin T, Keskinen R, Walker R, Bass J, Anglin TM. The psychosocial effects of acne on adolescents. Pediatr Dermatol 1991;8:332-8.
3. Malus M, LaChance PA, Lamy L, Macaulay A, Vanasse M. Priorities in adolescent health care: the teenager's viewpoint. J Fam Pract 1987;25:159-62.
4. Ebling FJ, Cunliffe WJ. Disorders of sebaceous glands. In: Rook A, Wilkinson DS, Ebling FJ, Champion RH, Burton JL, eds. Textbook of dermatology. Vol III. Boston: Blackwell Scientific, 1992:1699-744.
5. Leyden JJ. New understandings in the pathogenesis of acne. J Am Acad Dermatol 1995;32(5 pt 3):S15-25.
6. Facts and comparisons. St. Louis: Facts and Comparisons, 1999:3031-68.
7. Leyden JJ. Therapy for acne vulgaris. N Engl J Med 1997;336:1156-62.
8. Kligman AM. Acne vulgaris: tricks and treatments. Part II: the benzoyl peroxide saga. Cutis 1995;56: 260-1.
9. Ives TJ. Benzoyl peroxide. Am Pharm 1992;NS32 (8):33-8.
10. Zander E, Weisman S. Treatment of acne vulgaris with salicylic acid pads. Clin Ther 1992;14:247-53.
11. Shalita AR. Comparison of a salicylic acid cleanser and a benzoyl peroxide wash in the treatment of acne vulgaris. Clin Ther 1989;11:264-7.
12. Lin AN, Reimer RJ, Carter DM. Sulfur revisited. J Am Acad Dermatol 1988;18:553-8.
13. Breneman DL, Ariano MC. Successful treatment of acne vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion. Int J Dermatol 1993; 32:365-7.
14. Mackrides PS, Shaughnessy AF. Azelaic acid therapy for acne. Am Fam Physician 1996;54:2457-9.
15. Fitton A, Goa KL. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991;41:780-98.
16. Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil RP. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis 1996;57(1 suppl):20-35.
17. Orfanos CE, Ehlert R, Gollnick H. The retinoids. A review of their clinical pharmacology and therapeutic use. Drugs 1987;34:459-503.
18. Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet 1993; 341:1181-2.
19. Skov MJ, Quigley JW, Bucks DA. Topical delivery system for tretinoin: research and clinical implications. J Pharm Sci 1997;86:1138-43.
20. Webster GF. Topical tretinoin in acne therapy. J Am Acad Dermatol 1998;39(2 pt 3):S38-44.
21. Cunliffe WJ, Caputo R, Dreno B, Forstrom L, Heenen M, Orfanos CE, et al. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. J Am Acad Dermatol 1997; 36(6 pt 2):S126-34.
22. Caron D, Sorba V, Kerrouche N, Clucas A. Split face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients. J Am Acad Dermatol 1997;36(6 pt 2):S110-12.
23. Foster RH, Brogden RN, Benfield P. Tazarotene. Drugs 1998;55:705-11.
24. Leyden J. Open-label evaluation of topical antimicrobial and anti-acne preparations for effectiveness versus Propionibacterium acnes in vivo. Cutis 1992; 49:8-11.
25. Padilla RS, McCabe JM, Becker LE. Topical tetracycline hydrochloride vs. topical clindamycin phosphate in the treatment of acne. Int J Dermatol 1981;20:445-8.
26. Shalita AR, Chalker DK, Ellis CN, Parish LC, Smith JG. A multicenter, double-blind, controlled study of erythromycin/benzoyl peroxide, erythromycin alone, and benzoyl peroxide alone in the treatment of acne vulgaris. Cutis 1992;49:1-4.
27. Packman AM, Brown RH, Dunlap FE, Kraus SJ, Webster GF. Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion. Int J Dermatol 1996;35:209-11.
28. Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol 1994;131:331-6.
29. Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kempers SE, Huerter CJ, et al. Treatment of acne with a combination dindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997;37:590-5.
30. Rietschel RL, Duncan SH. Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Int J Dermatol 1983;22:41-3.